Who Paid My Doc
Rashmee Patil
Hepatology McAllen, TX Medical Doctor
NPI 1780943860 CMS profile 1376400
1100 E Dove Ave Ste 202, McAllen, TX 78504
General payments
$145,921
Research payments
$187
Ownership & investment interest
$0
Research they led as principal investigator
$3,138,823
Through program year 2025, Rashmee Patil of McAllen, TX is reported in the CMS Open Payments database as having received $145,921 across 100 general payments and $187 in research payments paid to them. Separately, studies naming them as principal investigator received $3,138,823 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 86th percentile of Hepatology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $100,474 | 61 | |
| 2024 | General | $28,036 | 24 | |
| 2024 | Research | $187 | 1 | |
| 2023 | General | $17,311 | 11 | |
| 2022 | General | $33 | 2 | |
| 2021 | General | $18 | 1 | |
| 2019 | General | $50 | 1 |
Beside peers
- Rashmee Patil
- Hepatology median
- Middle half of Hepatology
- National median
In program year 2025, general payments to Rashmee Patil were reported at $100,474. Among 186 Hepatology profiles paid that year, the median was $937 and the middle half received between $213 and $19,932.
Show as a table
| Year | Rashmee Patil | Hepatology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $50 | $1,151 | $155–$15,665 | $163 |
| 2020 | $0 | $1,450 | $116–$10,568 | $114 |
| 2021 | $18 | $1,165 | $89–$8,210 | $132 |
| 2022 | $33 | $546 | $125–$14,024 | $149 |
| 2023 | $17,311 | $417 | $118–$7,955 | $160 |
| 2024 | $28,036 | $619 | $148–$16,504 | $164 |
| 2025 | $100,474 | $937 | $213–$19,932 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
101 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hepatology in Texas
Related records
Hepatology in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Hepatology
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.